Federated Hermes’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-335,119
| Closed | -$120K | – | 2153 |
|
|
2024
Q2 | $120K | Hold |
335,119
| – | – | ﹤0.01% | 1548 |
|
|
2024
Q1 | $225K | Sell |
335,119
-5,574
| -2% | -$3.74K | ﹤0.01% | 1473 |
|
|
2023
Q4 | $185K | Sell |
340,693
-103,255
| -23% | -$56.1K | ﹤0.01% | 1523 |
|
|
2023
Q3 | $266K | Buy |
443,948
+3,013
| +0.7% | +$1.81K | ﹤0.01% | 1482 |
|
|
2023
Q2 | $573K | Buy |
440,935
+120,899
| +38% | +$157K | ﹤0.01% | 1325 |
|
|
2023
Q1 | $563K | Buy |
320,036
+178,507
| +126% | +$314K | ﹤0.01% | 1369 |
|
|
2022
Q4 | $444K | Sell |
141,529
-192,256
| -58% | -$604K | ﹤0.01% | 1397 |
|
|
2022
Q3 | $1.64M | Sell |
333,785
-395,565
| -54% | -$1.94M | ﹤0.01% | 972 |
|
|
2022
Q2 | $3.02M | Sell |
729,350
-354,854
| -33% | -$1.47M | 0.01% | 818 |
|
|
2022
Q1 | $6.3M | Buy |
1,084,204
+599,932
| +124% | +$3.49M | 0.01% | 723 |
|
|
2021
Q4 | $3.63M | Buy |
484,272
+476,288
| +5,966% | +$3.57M | 0.01% | 908 |
|
|
2021
Q3 | $72K | Buy |
+7,984
| New | +$72K | ﹤0.01% | 1816 |
|
|
2018
Q3 | – | Sell |
-1,387
| Closed | -$19K | – | 2318 |
|
|
2018
Q2 | $19K | Sell |
1,387
-425,435
| -100% | -$5.83M | ﹤0.01% | 1806 |
|
|
2018
Q1 | $8.11M | Buy |
426,822
+134,389
| +46% | +$2.55M | 0.02% | 487 |
|
|
2017
Q4 | $4.8M | Buy |
292,433
+115,639
| +65% | +$1.9M | 0.01% | 626 |
|
|
2017
Q3 | $2.65M | Buy |
176,794
+28,583
| +19% | +$429K | 0.01% | 795 |
|
|
2017
Q2 | $1.3M | Buy |
+148,211
| New | +$1.3M | ﹤0.01% | 1113 |
|
|
2016
Q1 | – | Sell |
-18,162
| Closed | -$166K | – | 2164 |
|
|
2015
Q4 | $166K | Buy |
+18,162
| New | +$166K | ﹤0.01% | 1503 |
|